THE COMPREHENSIVE COMPARISON OF THE EFFICACY OF FIRST-LINE DRUGS IN THE TREATMENT OF TYPE II DIABETES: METFORMIN, GLP-1 AGONISTS, AND SGLT2 INHIBITORS. International Journal of Innovative Technologies in Social Science, [S. l.], v. 6, n. 3(47), 2025. DOI: 10.31435/ijitss.3(47).2025.3884. Disponível em: https://rspublisher.org/index.php/ijitss/article/view/3884. Acesso em: 17 mar. 2026.